Learning that you are pregnant after 35 brings with it a mix of excitement and questions — particularly around prenatal testing. The landscape of prenatal screening and diagnostic testing has expanded considerably in recent years, and navigating the options can feel overwhelming without a clear overview of what each test involves and what it can and cannot tell you.
This guide aims to offer a research-informed overview of the most common prenatal tests recommended or available for women over 35. It is not intended to guide medical decisions — that conversation belongs with your OB/GYN or maternal-fetal medicine specialist — but it may help you arrive at those conversations better prepared.
Why Testing Discussions Change After 35
According to the American College of Obstetricians and Gynecologists (ACOG), advanced maternal age — typically defined as 35 or older at the time of delivery — is associated with a modestly increased likelihood of certain chromosomal variations in a pregnancy. The majority of pregnancies after 35 are healthy. Because of this statistical relationship, providers typically discuss a broader range of testing options with women 35 and older.
First Trimester Screening Options
Cell-Free DNA Screening (cfDNA / NIPT)
Cell-free DNA screening, often called NIPT, analyzes fragments of fetal DNA that circulate in the pregnant person’s bloodstream. It is a screening test — meaning it estimates the probability of certain chromosomal conditions rather than providing a definitive diagnosis. A positive NIPT result requires confirmation through further testing.
First Trimester Combined Screening
This approach combines a nuchal translucency ultrasound with blood tests measuring PAPP-A and free beta-hCG. Together with maternal age, these results calculate a probability estimate for certain chromosomal conditions. This screening is typically performed between 11 and 14 weeks.
Second Trimester Screening Options
Quad Screen
The quad screen is a blood test performed between approximately 15 and 20 weeks that measures four substances to calculate probability estimates for Down syndrome, trisomy 18, and neural tube defects. Like other screening tests, it identifies probabilities rather than certainties.
Anatomy Ultrasound
A detailed anatomy ultrasound, typically performed around 18 to 20 weeks, examines fetal anatomy in detail. It can identify structural variations that may prompt further evaluation. The anatomy scan is a standard part of prenatal care regardless of maternal age.
Diagnostic Tests: A Different Category
Screening tests estimate probabilities — they do not provide definitive answers. Diagnostic tests can provide a chromosomal diagnosis.
Chorionic Villus Sampling (CVS)
CVS is performed between approximately 10 and 13 weeks and involves sampling a small amount of placental tissue. The sample can be analyzed to provide a definitive chromosomal picture. CVS carries a small risk of pregnancy loss — current research suggests approximately 0.5-1% or less at experienced centers.
Amniocentesis
Amniocentesis is typically performed between 15 and 20 weeks and involves sampling a small amount of amniotic fluid to provide a definitive chromosomal diagnosis. Decisions about whether to pursue diagnostic testing are deeply personal and should be made in consultation with your healthcare team.
For more on what to expect emotionally during pregnancy after 35, you may find it helpful to read about managing anxiety during pregnancy after 35.
Genetic Counseling
For women with questions about their specific risk factors, a family history of genetic conditions, or abnormal screening results, genetic counseling can be a valuable resource. Genetic counselors specialize in helping individuals understand their options and interpret test results.
Frequently Asked Questions
Is prenatal testing mandatory after 35?
No. ACOG guidelines affirm that all pregnant women should be offered information about screening and diagnostic options, but participation is a personal decision.
What is the difference between screening and diagnostic testing?
Screening tests estimate the probability that a chromosomal condition is present. Diagnostic tests analyze fetal chromosomes directly and can provide a definitive result, but they involve a small procedural risk.
What happens if a screening test comes back high-probability?
A high-probability screening result means the test identified an elevated likelihood of a particular condition — not a diagnosis. The next step is typically a conversation with your provider or a genetic counselor about whether diagnostic testing makes sense for your situation.
Are there conditions that prenatal testing cannot detect?
Yes. Current prenatal screening focuses on chromosomal conditions and some structural variations. A normal prenatal test result does not guarantee a pregnancy without any health considerations.
Key Takeaways
- Women 35 or older at the time of delivery are typically offered a broader discussion of prenatal screening options due to a modest age-related increase in the likelihood of certain chromosomal variations.
- Screening tests estimate probabilities; diagnostic tests (amniocentesis, CVS) can provide definitive chromosomal results.
- Participation in prenatal testing is a personal decision — your healthcare provider can help you understand the options.
- Genetic counselors can provide specialized support in interpreting results and exploring options.
- Most pregnancies after 35 are healthy — prenatal testing is a tool for information, not a signal that something is expected to go wrong.
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.